Read the latest positive news, breakthroughs, and inspiring stories about pediatric health, curated daily by BrightWire.
Children with achondroplasia may soon replace daily injections with a simple once-a-day pill. Groundbreaking trial results from Cincinnati Children's Hospital offer families renewed freedom and healthy bone growth.
Children with idiopathic nephrotic syndrome just gained a powerful new treatment option. The FDA approved Gazyva for pediatric patients, offering hope to families navigating this challenging kidney condition.
Australian researchers discovered that most children labeled obese by traditional measurements are actually healthy and active. The new global definition focuses on real health impacts, not just body size.
A cystic fibrosis treatment is doing something doctors thought impossible: reversing pancreatic failure in young children. Nearly half of kids treated with Alyftrek no longer show signs of a digestive condition once considered permanent.
A Tampa teen is cancer-free after receiving a newly approved immunotherapy that spares young patients from harsh side effects. Leah Pshedesky, 17, is now heading to college with a renewed passion for music.
Brothers with hemophilia now surf six-foot waves and practice martial arts thanks to breakthrough medicines that prevent dangerous bleeding with just one shot every few weeks. These treatments are transforming a once-disabling condition into a manageable one for 30,000 Americans.
Children with spinal muscular atrophy who receive treatment shortly after birth are walking more often and experiencing fewer health complications than those treated later. New survey data from Cure SMA shows early intervention is transforming outcomes for kids with this genetic condition.
Researchers at the University of Alabama discovered how aggressive neuroblastoma spreads and found two drug targets that dramatically slowed tumor growth in testing. This breakthrough offers new hope for the 600 to 800 children diagnosed with this deadly cancer each year.
Children with a rare genetic liver disorder that often leads to transplant now have their first treatment to slow disease progression. After 20 years of research, Japanese doctors turned an existing drug into a life-changing option for young patients with PFIC.
Children and adults with spinal muscular atrophy now have access to the first therapy that directly targets muscle loss, offering new hope for independent movement. The breakthrough drug showed kids improving their motor skills while those on placebo declined.
Kids facing blood cancer now have better odds than ever, with survival rates climbing to 90 percent for the most common types. New targeted treatments and immunotherapies are transforming what was once a devastating diagnosis into a fight most children win.
Children and adults with a rare genetic disease that required eating every few hours can now receive a one-time gene therapy treatment. The FDA approval marks the first treatment to address the root cause of glycogen storage disease type Ia.